Literature DB >> 16706618

Use of frozen-thawed cervical tissues in the organ culture system to measure anti-HIV activities of candidate microbicides.

Phalguni Gupta1, Deena Ratner, Bruce K Patterson, Kathy Kulka, Lisa C Rohan, Michael A Parniak, Charles E Isaacs, Sharon Hillier.   

Abstract

Cervical tissue-based organ culture system has been used to test the cytotoxicity and antiviral activity of microbicides. One of the problems of using current organ culture methods for routine microbicide testing is the need to continually obtain fresh tissue, which can be limited in access and supply. Use of frozen tissue, stored when available and thawed when needed, would alleviate the need for constant access to new tissue. This study was designed to explore the possibility of using frozen-thawed cervical tissue to test microbicides for their anti-HIV activity. We provided biochemical, histological, and quantitative immunohistochemical data to demonstrate the integrity of the frozen-thawed organ culture system. Significant levels of HIV-1 mucosal transmission were noted with both fresh and frozen-thawed tissue, regardless of the coreceptor usage of the virus isolate. Furthermore, candidate microbicides UC781, beta-cyclodextrin, and octylglycerol inhibited HIV-1 transmission across the mucosa of frozen-thawed tissues with a level of efficiency similar to that of fresh tissues. Therefore, frozen-thawed cervical tissue in the organ culture system provides a practical and convenient model to screen topical microbicides for their ability to block sexual transmission of HIV-1, and reduces the problems associated with procurement of the numerous tissues required for evaluation and comparison of microbicide candidates among different laboratories.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16706618     DOI: 10.1089/aid.2006.22.419

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

1.  Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture.

Authors:  Phalguni Gupta; Deena Ratner; Ming Ding; Bruce Patterson; Lisa C Rohan; Todd A Reinhart; Velpandi Ayyavoo; Xioli Huang; Dorothy L Patton; Bharat Ramratnam; Alexander M Cole
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

2.  Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis.

Authors:  Nicola Richardson-Harman; Carol Lackman-Smith; Patricia S Fletcher; Peter A Anton; James W Bremer; Charlene S Dezzutti; Julie Elliott; Jean-Charles Grivel; Patricia Guenthner; Phalguni Gupta; Maureen Jones; Nell S Lurain; Leonid B Margolis; Swarna Mohan; Deena Ratner; Patricia Reichelderfer; Paula Roberts; Robin J Shattock; James E Cummins
Journal:  J Clin Microbiol       Date:  2009-09-02       Impact factor: 5.948

3.  Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.

Authors:  Melanie Merbah; Andrea Introini; Wendy Fitzgerald; Jean-Charles Grivel; Andrea Lisco; Christophe Vanpouille; Leonid Margolis
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

4.  Full depth measurement of tenofovir transport in rectal mucosa using confocal Raman spectroscopy and optical coherence tomography.

Authors:  Aubrey L Presnell; Oranat Chuchuen; Morgan G Simons; Jason R Maher; David F Katz
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

5.  Nonreproducibility of "snap-frozen" rectal biopsies for later use in ex vivo explant infectibility studies.

Authors:  Ian McGowan; Karen Tanner; Julie Elliott; Javier Ibarrondo; Elena Khanukhova; Charina McDonald; Terry Saunders; Ying Zhou; Peter A Anton
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09-04       Impact factor: 2.205

6.  Caveats associated with the use of human cervical tissue for HIV and microbicide research.

Authors:  Deborah J Anderson; Jeffrey Pudney; Danny J Schust
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

7.  Killing of Neisseria gonorrhoeae, Streptococcus agalactiae (group B streptococcus), Haemophilus ducreyi, and vaginal Lactobacillus by 3-O-octyl-sn-glycerol.

Authors:  B J Moncla; K Pryke; Charles E Isaacs
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

8.  HIV-1 infection of female genital tract tissue for use in prevention studies.

Authors:  Charlene S Dezzutti; Kevin Uranker; Katherine E Bunge; Nicola Richardson-Harman; Ingrid Macio; Sharon L Hillier
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-15       Impact factor: 3.731

9.  A study of the osmotic characteristics, water permeability, and cryoprotectant permeability of human vaginal immune cells.

Authors:  Zhiquan Shu; Sean M Hughes; Cifeng Fang; Jinghua Huang; Baiwen Fu; Gang Zhao; Michael Fialkow; Gretchen Lentz; Florian Hladik; Dayong Gao
Journal:  Cryobiology       Date:  2016-03-11       Impact factor: 2.487

10.  Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial.

Authors:  Charlene S Dezzutti; Nicola Richardson-Harman; Lisa C Rohan; Mark A Marzinke; Craig J Hoesley; Lori Panther; Sherri Johnson; Jeremy P Nuttall; Annalene Nel; Beatrice A Chen
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.